The International Symposium on Malignant Mesothelioma, scheduled for April 6-7 in San Antonio, Texas, has been postponed due to concerns over the spread of the coronavirus, COVID-19, the Mesothelioma Applied Research Foundation said in a news release.
“This decision comes after careful deliberation and consultation with experts in the medical field who focus on the care of mesothelioma patients, as well as a review of new information released today regarding the risk to patients with thoracic malignancies,” the organization said.
The severity of COVID-19 symptoms can range from very mild to severe and include fever, cough, and shortness of breath or difficulty breathing, according to the Centers for Disease Control and Prevention (CDC). Similar to influenza, people who are older or have existing medical conditions, such as mesothelioma patients, may be at higher risk of serious illness if they contract COVID-19.
Mesothelioma is a rare form of cancer linked to asbestos exposure. It develops in the lining of the lungs, abdomen, or other internal organs.
“As you are well aware, our patient population is at the highest risk for complications from a possible infection with this virus so this course of action seems most responsible,” according to the release. “Moreover, in consulting with physicians who treat mesothelioma patients, we learned that some institutions have begun banning work-related travel. Other physicians at institutions without bans are nevertheless uneasy about travel because of the risk of spreading infection upon return to their patients in their daily work.”
The organization is working with the hotel to reschedule the conference and will release the new dates once they are confirmed. Those who have already registered for the event have been notified of the change. For more information, contact the Mesothelioma Applied Research Foundation at email@example.com.
Beasley Allen attorneys are looking at cases of industrial, occupational and secondary asbestos exposure resulting in lung cancer or mesothelioma as well as claims of asbestos-related talc products linked to mesothelioma.